RPG Life Sciences Limited (RPGLIFE) reports 15.8% revenue growth in Q1 FY27, with EBITDA margin expanding to 24.5%.
RPG Life Sciences partners with Archerchem Healthcare to launch Naprosyn ES, a new anti-inflammatory and gastro-protection combo, addressing unmet needs in c.